Sofiva Genomics (6615) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 慧智

Sofiva Genomics (6615) reported revenue of NT$30.2 million for Oct 2026, -3.0% year on year and -1.2% from the previous month. Revenue for Jan–Oct 2026 was NT$314.9 million (-1.9% year on year).

In Oct 2026, it ranked No. 118 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$36.1 million24/10Nov 2024 NT$32.4 millionDec 2024 NT$34.9 millionJan 2025 NT$31.1 millionFeb 2025 NT$31.4 million25/02Mar 2025 NT$33.4 millionApr 2025 NT$33.2 millionMay 2025 NT$34.3 millionJun 2025 NT$33.2 million25/06Jul 2025 NT$32.3 millionAug 2025 NT$31.1 millionSep 2025 NT$30 millionOct 2025 NT$31.1 million25/10Nov 2025 NT$30.9 millionDec 2025 NT$33.7 millionJan 2026 NT$33.1 millionFeb 2026 NT$26.4 million26/02Mar 2026 NT$34.4 millionApr 2026 NT$30.2 millionMay 2026 NT$33.7 millionJun 2026 NT$32.3 million26/06Jul 2026 NT$33.7 millionAug 2026 NT$30.4 millionSep 2026 NT$30.5 millionOct 2026 NT$30.2 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$30.2 million-3.0%-1.2%
Sep 2026NT$30.5 million+1.8%+0.6%
Aug 2026NT$30.4 million-2.4%-9.8%
Jul 2026NT$33.7 million+4.3%+4.1%
Jun 2026NT$32.3 million-2.5%-4.2%
May 2026NT$33.7 million-1.7%+11.9%
Apr 2026NT$30.2 million-9.1%-12.2%
Mar 2026NT$34.4 million+2.8%+30.0%
Feb 2026NT$26.4 million-15.7%-20.1%
Jan 2026NT$33.1 million+6.3%-1.9%
Dec 2025NT$33.7 million-3.4%+9.3%
Nov 2025NT$30.9 million-4.9%-0.8%
Oct 2025NT$31.1 million-13.9%+3.7%
Sep 2025NT$30 million-11.3%-3.6%
Aug 2025NT$31.1 million-17.8%-3.5%
Jul 2025NT$32.3 million-6.6%-2.7%
Jun 2025NT$33.2 million-19.7%-3.4%
May 2025NT$34.3 million-13.6%+3.5%
Apr 2025NT$33.2 million-20.0%-0.8%
Mar 2025NT$33.4 million-22.3%+6.6%
Feb 2025NT$31.4 million-12.5%+0.8%
Jan 2025NT$31.1 million-26.2%-10.9%
Dec 2024NT$34.9 million-13.6%+7.6%
Nov 2024NT$32.4 million-9.2%-10.1%
Oct 2024NT$36.1 million-6.7%+6.8%

Jan–Oct 2026 cumulative: NT$314.9 million (-1.9% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Sofiva Genomics vs PEC / Sofiva Genomics vs Lotus Pharm / Sofiva Genomics vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16